Opens in a new tab
Monday, 16 November 2026
EVIDENCE. INTERPRETED.
Policy & Acquisitions

Mergers & Acquisitions

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Mergers & Acquisitions

214 stories · every one Fact-Checked
Stunning view of the Abu Dhabi skyline reflecting in the calm Gulf waters on a sunny day.Mergers & AcquisitionsJohnson & Johnson Builds AI-Powered Surgical Network in Abu DhabiPexels Johnson & Johnson MedTech and the Department of Health – Abu Dhabi have launched the world’s first global hub…21 May 2026 · 2 min read
Fact-Checked
Visual abstraction of neural networks in AI technology, featuring data flow and algorithms.Mergers & AcquisitionsBMS Integrates Claude AI into Research, Clinical Development, and ManufacturingBristol Myers Squibb has expanded its enterprise AI strategy through a collaboration with Anthropic, rolling out Claude to more than 30,000 employees.21 May 2026 · 3 min read
Fact-Checked
Incyte_logo.svgMergers & AcquisitionsIncyte Expands Molecular AI Collaboration With Genesis TherapeuticsIncyte and Genesis Therapeutics have broadened their strategic collaboration to accelerate AI-driven small molecule drug discovery.20 May 2026 · 3 min read
Fact-Checked
A new homeowner receives keys inside their new home, symbolizing a fresh start.Mergers & AcquisitionsHansa Licenses IDEFIRIX Rights to SERB in €115 Million DealHansa Biopharma signed an exclusive licensing agreement with SERB for the development and commercialization of IDEFIRIX across Europe and MENA.19 May 2026 · 3 min read
Fact-Checked
A robotic hand reaching into a digital network on a blue background, symbolizing AI technology.Mergers & AcquisitionsIncyte Collaborates With Edison Scientific on AI-Driven Drug DiscoveryIncyte has partnered with Edison Scientific to deploy the AI platform Kosmos across its research and development operations.19 May 2026 · 2 min read
Fact-Checked
hands, puzzle pieces, connect, connection, cooperation, holding, isolated, jigsaw, join, partnership, people, pieces, puzzle, teamwork, two, unity, monochrome, idea, concept, black and white, hands, hands, connect, connect, connection, connection, connection, cooperation, cooperation, partnership, partnership, partnership, people, people, people, people, puzzle, puzzle, puzzle, puzzle, puzzle, teamwork, teamwork, teamwork, teamwork, two, idea, idea, ideaMergers & AcquisitionsRegeneron and Parabilis Partner to Develop Antibody-Helicon ConjugatesRegeneron partnered with Parabilis Medicines to develop Antibody-Helicon Conjugates, investigational therapies that combine antibody targeting with intracellular Helicon peptide delivery for historically “undruggable” proteins.18 May 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_1lw8ct1lw8ct1lw8Mergers & AcquisitionsImmunityBio Secures Exclusive U.S. Rights to Tokyo-172 BCG for Bladder CancerImmunityBio signed an exclusive agreement with Japan BCG Laboratory to develop and commercialize Tokyo-172 BCG in the United States after Phase III SWOG S1602 data demonstrated non-inferiority to…18 May 2026 · 2 min read
Fact-Checked
A group of children with UNICEF backpacks walking on a dirt road in rural Syria.Mergers & AcquisitionsEli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICsEli Lilly and Company will invest $50 million over six years to support UNICEF USA programs focused on strengthening healthcare systems, improving early diagnosis, and expanding long-term care…14 May 2026 · 2 min read
Fact-Checked
Gemini_Generated_Image_wgpzoiwgpzoiwgpzMergers & AcquisitionsEnodia Therapeutics Acquires Sec61-Based Assets from Kezar Life SciencesEnodia Therapeutics acquired Kezar Life Sciences’ Sec61 program assets, including KZR-261, in a transaction featuring $1 million upfront and up to $127 million in milestone payments to advance…14 May 2026 · 2 min read
Fact-Checked
Boehringer Ingelheim's investigational dual GLP-1 and glucagon receptor agonist survodutide meets the cardiovascular safety endpoint in the Phase III SYNCHRONIZE-CVOT trial.Mergers & AcquisitionsBoehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Inflammatory DiseasesBoehringer Ingelheim inks global deal with Immunitas Therapeutics for a novel preclinical antibody targeting chronic inflammatory diseases.13 May 2026 · 2 min read
Fact-Checked
aRVINASMergers & AcquisitionsRigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANURigel Pharmaceuticals secured exclusive global rights to VEPPANU (vepdegestrant) from Arvinas and Pfizer, taking over commercialization of the first FDA-approved PROTAC therapy for ESR1-mutated ER+/HER2- advanced breast cancer.…12 May 2026 · 2 min read
Fact-Checked
simon-l-NfD89_IK3mY-unsplashMergers & AcquisitionsBMS and Hengrui Forge a $15.2 Billion Drug Discovery AllianceUnsplash Bristol Myers Squibb and Hengrui Pharma entered a global strategic collaboration covering 13 early-stage oncology, hematology, and immunology programs…12 May 2026 · 3 min read
Fact-Checked
Page 12 of 18